article thumbnail

10 Tips for Buying CBD Oil

Project CBD

In June 2018, the Food and Drug Administration ( FDA ) gave its blessing to “Epidiolex,” a purfied CBD pharmaceutical, for treating severe pediatric epilepsy. Six months later, Congress passed the Farm Bill, which legalized the cultivation of industrial hemp for many uses, including the production of biomass for CBD oil extraction.

Oil 237
article thumbnail

10 Tips for Buying Hemp-Derived CBD Products

Project CBD

With Congress seemingly poised to legalize the cultivation of industrial hemp for many uses, including the production of biomass for CBD oil extraction, many questions remain unanswered. How will the DEA reschedule CBD now that Epidiolex has been approved as a pharmaceutical CBD isolate?

Hemp 203
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Thailand explores hemp extraction for medical research

Cannabis Law Report

Experts at Khon Kaen University (KKU) in Thailand recently gathered to discuss research and academic collaboration related to hemp extraction in order to develop hemp products. Khon Kaen University has announced to enter agreements for using hemp extracts in more products. Charnchai Panthongviriyakul, M.D.,

article thumbnail

GW Pharma Scores Interim Victory In Cannabis Extraction Patent Infringement Fight With Canopy (Op-Ed)

Cannabis Law Report

Albright issued a claim construction order favoring GW Pharmaceuticals in the high-stakes, high-profile cannabis patent litigation brought by Canopy Growth Corporation. GW Pharma Scores Interim Victory In Cannabis Extraction Patent Infringement Fight With Canopy (Op-Ed). Canopy has accused GW of infringing U.S.

article thumbnail

The Pharmaceutical Industry’s Relationship With Cannabis

Kind Meds (Cannabis Education Blog)

At the same time, the pharmaceutical industry has become one of the most powerful businesses in the country. Big Pharma, which includes ten of the largest powers of the pharmaceutical industry, like businesses such as Johnson & Johnson, are heavily influential when it comes to political decisions in the U.S.

article thumbnail

The Cannabis Cancer Connection

Project CBD

United Kingdom-based GW Pharmaceuticals has produced the world’s first approved cannabis-based medicines for the UK, US, and European markets, Sativex® and Epidiolex®. GW Pharmaceuticals’ research on glioblastoma multiforme (GBM) is important and promising. Note: In May 2021, GW Pharmaceuticals was acquired by Jazz Pharmaceuticals.]

article thumbnail

Report: “Key pharmacological differences between side effects of refined, pharmaceutical CBD formulations and whole plant extracts:”

Cannabis Law Report

However, there are indications from studies done with cannabidiol-rich cannabis extracts in Israel that indicate that less side effects (46%) are achieved with a natural cannabis plant extract containing a 20:1 ratio of CBD to THC. The CBD-rich extract group had a lower effective dose on average, 6.1